A somaticBRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain
- 8 February 1999
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 24 (3) , 207-212
- https://doi.org/10.1002/(sici)1098-2264(199903)24:3<207::aid-gcc5>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PTEN1 is frequently mutated in primary endometrial carcinomasNature Genetics, 1997
- Mutational Analysis of the BRCA1 Tumor Suppressor Gene in Endometrial CarcinomaGynecologic Oncology, 1997
- Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13American Journal of Human Genetics, 1997
- Functional analysis of the polypyrimidine tract in pre-mRNA splicingNucleic Acids Research, 1997
- Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneNature Genetics, 1997
- Lessons from Hereditary Colorectal CancerCell, 1996
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994
- Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisNature, 1993
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990